Taconic Biosciences' Dr. Jochen Welcker was recently interviewed by Drug Discovery News about utilizing CRISPR for gene editing, and... Read More
Focus Feature on Gene Editing: Catching up on CRISPR
Jun 02, 2020
Taconic Biosciences' Dr. Jochen Welcker was recently interviewed by Drug Discovery News about utilizing CRISPR for gene editing, and... Read More
First Animal Model Provider to Create Program Aiding Researchers Planning for Return Rensselaer, NY, — May 18, 2020 -... Read More
The 23rd Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) will be taking place virtually... Read More
Genetically engineered animal models (GEMs) are essential tools for preclinical research but can be difficult to license depending on... Read More
Taconic's Dr. Alexander Maue recently authored a follow-up article for International Biopharmaceutical Industry (IBI) to his original comment on... Read More
Recent research into the microbiome demonstrates that the composition of gut microbiota influences the development and progression of disease.... Read More
SIOP is an important process for many companies, and of prime importance for mouse model generation. Taconic's Terry Receveur... Read More
In a recent article for Drug Target Review, Taconic's Dr. Paul Volden emphasizes how humanized immune system (HIS) mouse... Read More
Announces Preclinical COVID-19 Research Tools Rensselaer, NY — March 20, 2020 - Taconic Biosciences, a global leader in providing... Read More
The concept of T cell exhaustion and the associated immune response has become a priority for immuno-oncology researchers. Taconic's... Read More
Welcome! Tell us a little about yourself